Projects per year
- 1 - 50 out of 82 results
Search results
-
Active
-
-
Efficacy of Marburg virus monoclonal antibody (IBT-T03) in guinea pig model of MARV-Angola infection
11/11/21 → 6/1/22
Project: Other project
-
Efficacy of Marburg virus monoclonal antibody (IBT-T03) in guinea pig model of MARV-Angola infection
11/11/21 → 6/1/22
Project: Other project
-
Determination of the EC50 and EC90 of favipiravir against SARS-CoV-2
10/1/21 → 8/31/22
Project: Other project
-
Determination of the EC50 and EC90 of favipiravir against SARS-CoV-2
10/1/21 → 8/31/22
Project: Other project
-
Development of an aerosol induced nonhuman primate model of Lassa fever
7/30/21 → 8/31/26
Project: Other project
-
Development of an aerosol induced nonhuman primate model of Lassa fever
7/30/21 → 8/31/26
Project: Other project
-
Development of an aerosol induced nonhuman primate model of Lassa fever
7/30/21 → 8/31/26
Project: Other project
-
-
Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model
6/1/21 → 5/31/23
Project: Other project
-
-
Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model
6/1/21 → 5/31/23
Project: Other project
-
Preclinical development of a vaccine for Nipah virus
National Inst of Allergy & Infectious Di
3/11/21 → 2/28/26
Project: Other project
-
Preclinical development of a vaccine for Nipah virus
National Inst of Allergy & Infectious Di
3/11/21 → 2/28/26
Project: Other project
-
Development of a rVSV-Vectored Vaccine for Lassa Virus: Nonhuman Primate Efficacy and Immunogenicity Studies
1/1/21 → 12/1/24
Project: Other project
-
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
National Inst of Allergy & Infectious Di
7/15/20 → 6/30/25
Project: Other project
-
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
7/15/20 → 6/30/25
Project: Other project
-
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
National Inst of Allergy & Infectious Di
7/15/20 → 6/30/25
Project: Other project
-
Preclinical Development of a Crimean-Congo Hemorrhagic Fever Virus Vaccine
7/15/20 → 6/30/25
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 4/1/23
Project: Other project
-
Development of a Recombinant VSV-Based Vaccine for Nipah Virus
9/1/19 → 8/31/22
Project: Other project
-
Development of a Recombinant VSV-Based Vaccine for Lassa Fever
9/1/19 → 8/31/22
Project: Other project
-
Development of a Recombinant VSV-Based Vaccine for Lassa Fever
9/1/19 → 8/31/22
Project: Other project
-
Development of a Recombinant VSV-Based Vaccine for Nipah Virus
9/1/19 → 8/31/22
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
3/27/19 → 9/30/22
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
3/27/19 → 9/30/22
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
3/27/19 → 9/30/22
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
3/27/19 → 9/30/22
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
3/27/19 → 9/30/22
Project: Other project
-
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
National Inst of Allergy & Infectious Di
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
National Inst of Allergy & Infectious Di
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
National Inst of Allergy & Infectious Di
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
National Inst of Allergy & Infectious Di
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
National Inst of Allergy & Infectious Di
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
3/8/19 → 2/29/24
Project: Other project
-
ADVANCEMENT OF VACCINES AND TREATMENTS FOR EBOLA AND MARBURG VIRUS INFECTIONS
National Inst of Allergy & Infectious Di
3/8/19 → 2/29/24
Project: Other project